In conclusion, our study reported the identification of a novel prognostic and diagnostic marker, NEU1, which promotes HCC cell proliferation and migration through spliceosome pathway, which may provide a new target for the treatment of HCC in future. Here, NEU1 is linked to hepatocellular carcinoma.